Women's Hormone & Midlife Health

What hormones actually do across a woman's life

A woman's hormones shift across her whole life, not only at menopause. Estrogen, progesterone, testosterone, and thyroid hormones drive the menstrual cycle through the reproductive years, change through pregnancy and postpartum, and decline through perimenopause and after. Each stage has its own symptoms and its own clinical options, and the online care market now sells treatment for most of them.

Perimenopause is the stage drawing the most attention right now. Estrogen production begins declining, for most women, sometime in the mid-40s, years before menopause is formally diagnosed. Progesterone drops alongside it, and for some women testosterone declines too. Hot flashes, disrupted sleep, brain fog, mood changes, joint pain, and changes in libido and vaginal tissue are the predictable downstream effects, and they tend to be underestimated in both their frequency and their impact on daily functioning.

Menopause itself is confirmed after twelve consecutive months without a period, and symptoms can persist for years after. Many women move through these stages with limited information, often because their primary care visits haven't surfaced any of it as something worth discussing. That gap in the standard of care is part of what created the current market for women's health platforms, and part of what makes evaluating those platforms carefully worth your time.

What HRT is and how it works

HRT is one area within women's health, not the whole vertical. Providers in this directory also manage thyroid conditions, prescribe testosterone, offer GLP-1 medications for weight, and treat sexual and vaginal health. HRT is one of the most studied areas of women's hormone care, which is why it is worth understanding first. Hormone replacement therapy replaces estrogen and progesterone (and sometimes testosterone) that the body produces less of during perimenopause and after menopause. It reliably reduces hot flashes, improves sleep quality, manages vaginal symptoms, and supports bone density. The clinical evidence today is strong enough that major menopause societies, including the North American Menopause Society, recommend it as a first-line option for women without specific contraindications.

The hesitation that followed the 2002 Women's Health Initiative study, which linked HRT to increased breast cancer and cardiovascular risk, was driven partly by data specific to older postmenopausal women on oral synthetic hormones. More recent reanalysis has substantially changed that risk framing. For women under 60, or within 10 years of menopause onset, the benefit-risk picture looks different from what the 2002 coverage suggested. Delivery method also matters: transdermal estrogen (patches, gels) carries a different, generally lower, cardiovascular risk profile than oral estrogen because of how it's processed by the liver.

Compounded bioidentical hormonesare widely marketed as a more natural alternative. They are not FDA-approved, and the quality of compounded formulations varies significantly by pharmacy. A provider who doesn't explain the distinction between branded FDA-approved products and compounded alternatives is leaving you to make an uninformed decision. That's one of the first things worth asking when you evaluate a women's health platform.

How to evaluate a women's health provider

The signals Vial checks are public records. They don't tell you whether a specific protocol is right for you medically, but they do tell you whether a provider is operating at a basic standard of legitimacy. Here is what those signals look like, and why each one matters.

• Licensed prescriber

  Is the physician actually licensed in your state? NPI records are public and searchable. Vial checks them. A provider operating across 40 states should have verifiable licensed prescribers in each.

• Board certification in menopause care

  The North American Menopause Society Certified Practitioner (MSCP) credential is the relevant benchmark. Not all providers disclose whether their physicians hold it. A platform with 50 states of coverage and no disclosed credentials is worth a follow-up question.

• OIG exclusion and FDA enforcement record

  The OIG exclusion list is the federal registry of providers barred from Medicare and Medicaid for fraud or misconduct. FDA enforcement actions and warning letters are public. Vial checks both. A clean record isn't a guarantee, but a dirty one is information worth having before you pay.

• Pharmacy partner disclosure

  For compounded HRT, knowing which pharmacy fills your prescription is the compliance signal that matters most. Is the pharmacy named? Is it PCAB-accredited? Providers that don't disclose their pharmacy partner make it impossible to verify quality independently.

• Actual physician involvement

  Telehealth platforms vary from specialist-direct care to protocol-driven access with minimal physician involvement. "Physician-supervised" means different things at different platforms. Ask whether you're assigned a specific doctor, how often they review your labs, and what the process is if your protocol isn't working.

• All-in pricing transparency

  The number on the marketing page is usually the consultation fee. Medication, shipping, and lab monitoring are often separate. Ask for a total monthly number before you commit to a membership.

HRT & Hormone Health Guides

Women's health providers scored by Vial

Sorted by Vial Score. Showing 9 of 9 providers. See all women's health providers →